niclosamide has been researched along with Co-infection in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, X | 1 |
| Xu, J | 1 |
| Files, M | 1 |
| Cirillo, JD | 1 |
| Endsley, JJ | 1 |
| Zhou, J | 1 |
| Endsley, MA | 1 |
1 other study available for niclosamide and Co-infection
| Article | Year |
|---|---|
Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing).
Topics: Anti-HIV Agents; Antitubercular Agents; Coinfection; HIV-1; Humans; Jurkat Cells; Macrophages; Mycob | 2019 |